PUBLISHER: The Business Research Company | PRODUCT CODE: 1942660
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942660
Dental bone graft substitutes are biocompatible substances utilized in oral and maxillofacial surgery to facilitate bone regeneration and restore lost or damaged bone tissue in the jaw or oral cavity. These substitutes are typically employed when a patient lacks sufficient natural bone volume or density, often due to tooth extraction, periodontal disease, trauma, or other dental conditions.
The primary types of dental bone graft substitutes include xenograft, allograft, autograft, and others. A xenograft dental bone graft substitute encompasses various materials, such as hydroxyapatite, tricalcium phosphate, calcium phosphate, and others. These materials operate through mechanisms such as osteoconduction, osteoinduction, osteogenesis, and osteopromotion. They find applications in ridge augmentation, sinus lift, socket preservation, and addressing periodontal defects. End users of these substitutes include hospitals, dental clinics, and other healthcare facilities.
Tariffs are impacting the dental bone graft substitutes market by increasing costs of imported biomaterials, processing equipment, sterilization inputs, and specialty packaging materials. Hospitals and dental clinics in North America and Europe are most affected due to reliance on imported graft materials, while Asia-Pacific faces cost pressures on material exports. These tariffs are raising treatment costs and influencing material selection. However, they are also supporting local biomaterial production, regional innovation in synthetic grafts, and supply chain localization.
The dental bone graft substitutes market research report is one of a series of new reports from The Business Research Company that provides dental bone graft substitutes market statistics, including dental bone graft substitutes industry global market size, regional shares, competitors with a dental bone graft substitutes market share, detailed dental bone graft substitutes market segments, market trends and opportunities, and any further data you may need to thrive in the dental bone graft substitutes industry. This dental bone graft substitutes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dental bone graft substitutes market size has grown strongly in recent years. It will grow from $4.41 billion in 2025 to $4.65 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing prevalence of periodontal disease, growth in dental implant procedures, advancements in biomaterial science, expansion of oral surgery practices, improved patient awareness of restorative options.
The dental bone graft substitutes market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing demand for bioengineered graft materials, rising focus on minimally invasive grafting techniques, expansion of regenerative dental therapies, growing adoption of guided bone regeneration, increasing investment in advanced biomaterials. Major trends in the forecast period include increasing adoption of synthetic bone graft materials, rising demand for implant-supported procedures, growing use of osteoconductive biomaterials, expansion of regenerative dentistry applications, enhanced focus on faster bone healing.
The rising prevalence of dental disorders is expected to drive the growth of the dental bone graft substitute market in the coming years. Dental disorders include a range of medical conditions and health issues that affect the oral cavity, encompassing the teeth, gums, tongue, lips, cheeks, palate, and other structures within the mouth. Dental bone graft substitutes are used in the treatment of dental disorders to address jawbone deficiencies or to support dental implant placement by providing a scaffold for new bone formation. For example, in August 2024, according to The Conversation U.S., a US-based publication company, the proportion of the UK population affected by gum disease is projected to increase from 42% at present to 54% by 2050. Consequently, the increasing prevalence of dental disorders is contributing to the growth of the dental bone graft substitute market.
Major companies in the dental bone graft substitute market are focusing on developing innovative products such as regenerOss CC allograft particulate and regenerOss bone graft plug to enhance their services. RegenerOss CC allograft particulate is a dental bone graft substitute material containing a natural blend of cortical and cancellous bone particles to promote bone regeneration in the oral cavity. RegenerOss bone graft plug is a solution for filling extraction sockets and periodontal defects. For example, in April 2023, ZimVie Inc., a US-based medical instrument manufacturing company, introduced RegenerOss CC Allograft Particulate and RegenerOss Bone Graft Plug, designed for minimally invasive procedures that can be performed in an office setting. These products, made from bovine bone, offer a safe and effective way to repair or reconstruct the jaw, applicable in various dental applications.
In April 2024, Geistlich Pharma India Pvt. Ltd., a Switzerland-based dental biomaterials company, acquired Bionnovation Biomedical, a Brazil-based firm, for an undisclosed amount. Through this acquisition, Geistlich seeks to enhance its capabilities in regenerative dentistry and dental bone graft substitutes, with a focus on delivering advanced solutions for periodontists, oral surgeons, and clinicians specializing in implant dentistry. Bionnovation Biomedical LTDA specializes in the development of innovative biomaterials for bone regeneration in dental applications.
Major companies operating in the dental bone graft substitutes market are Johnson and Johnson Services Inc., Zimmer Biomet Holdings Inc., Dentsply Sirona, Straumann Group, ZimVie Inc., LifeNet Health, RTI Surgicals Inc., Dentium Co. Ltd., BioHorizons Inc., Keystone Dental Inc., Geistlich Pharma AG, MIS Implants Technologies Ltd., Collagen Matrix Inc., Salvin Dental Specialties Inc., Osteogenics Biomedical Inc., Botiss biomaterials GmbH, Curasan Inc., Novabone Products LLC, Biomatlante S.A, Carmell Therapeutics Corp., Neobiotech Co. Ltd., Silfradent S.r.l.
North America was the largest region in the dental bone graft substitutes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dental bone graft substitutes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the dental bone graft substitutes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The dental bone graft substitutes market consists of sales of demineralized bone matrix (DBM), ceramic-based bone grafts, calcium sulfate bone grafts, and synthetic bone graft substitutes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Dental Bone Graft Substitutes Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses dental bone graft substitutes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for dental bone graft substitutes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dental bone graft substitutes market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.